TY - JOUR
T1 - Phase-locked transcranial electrical brain stimulation for tremor suppression in dystonic tremor syndromes
AU - Nieuwhof, Freek
AU - Toni, Ivan
AU - Buijink, Arthur W. G.
AU - van Rootselaar, Anne-Fleur
AU - van de Warrenburg, Bart P. C.
AU - Helmich, Rick C.
N1 - Funding Information: We thank our participants for their time and commitment to the study. Also, we thank Uriël Plönes for his technical support in developing phase-locked TACS. This project was funded by the Dutch Brain Foundation (Hersenstichting) and the Benny Vleerlaag fonds. Publisher Copyright: © 2022 International Federation of Clinical Neurophysiology
PY - 2022/8/1
Y1 - 2022/8/1
N2 - Objective: To establish the causal role of the cerebellum and motor cortex in dystonic tremor syndromes, and explore the therapeutic efficacy of phase-locked transcranial alternating current stimulation (TACS). Methods: We applied phase-locked TACS over the ipsilateral cerebellum (N = 14) and contralateral motor cortex (N = 17) in dystonic tremor syndrome patients, while patients assumed a tremor-evoking posture. We measured tremor power using accelerometery during 30 s stimulation periods at 10 different phase-lags (36-degrees increments) between tremor and TACS for each target. Post-hoc, TACS-effects were related to a key clinical feature: the jerkiness (regularity) of tremor. Results: Cerebellar TACS modulated tremor amplitude in a phase-dependent manner, such that tremor amplitude was suppressed or enhanced at opposite sides of the phase-cycle. This effect was specific for patients with non-jerky (sinusoidal) tremor (n = 10), but absent in patients with jerky (irregular) tremor (n = 4). Phase-locked stimulation over the motor cortex did not modulate tremor amplitude. Conclusions: This study indicates that the cerebellum plays a causal role in the generation of (non-jerky) dystonic tremor syndrome. Our findings suggest pathophysiologic heterogeneity between patients with dystonic tremor syndrome, which mirrors clinical variability. Significance: We show tremor phenotype dependent involvement of the cerebellum in dystonic tremor syndrome. Tremor phenotype may thus guide optimal intervention targets.
AB - Objective: To establish the causal role of the cerebellum and motor cortex in dystonic tremor syndromes, and explore the therapeutic efficacy of phase-locked transcranial alternating current stimulation (TACS). Methods: We applied phase-locked TACS over the ipsilateral cerebellum (N = 14) and contralateral motor cortex (N = 17) in dystonic tremor syndrome patients, while patients assumed a tremor-evoking posture. We measured tremor power using accelerometery during 30 s stimulation periods at 10 different phase-lags (36-degrees increments) between tremor and TACS for each target. Post-hoc, TACS-effects were related to a key clinical feature: the jerkiness (regularity) of tremor. Results: Cerebellar TACS modulated tremor amplitude in a phase-dependent manner, such that tremor amplitude was suppressed or enhanced at opposite sides of the phase-cycle. This effect was specific for patients with non-jerky (sinusoidal) tremor (n = 10), but absent in patients with jerky (irregular) tremor (n = 4). Phase-locked stimulation over the motor cortex did not modulate tremor amplitude. Conclusions: This study indicates that the cerebellum plays a causal role in the generation of (non-jerky) dystonic tremor syndrome. Our findings suggest pathophysiologic heterogeneity between patients with dystonic tremor syndrome, which mirrors clinical variability. Significance: We show tremor phenotype dependent involvement of the cerebellum in dystonic tremor syndrome. Tremor phenotype may thus guide optimal intervention targets.
KW - Dystonia
KW - Electrical stimulation
KW - Transcranial alternating current stimulation
KW - Tremor
UR - http://www.scopus.com/inward/record.url?scp=85131138729&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.clinph.2022.03.020
DO - https://doi.org/10.1016/j.clinph.2022.03.020
M3 - Article
C2 - 35469732
SN - 1388-2457
VL - 140
SP - 239
EP - 250
JO - Clinical neurophysiology
JF - Clinical neurophysiology
ER -